J
Jing Li
Researcher at Jilin University
Publications - 97
Citations - 3604
Jing Li is an academic researcher from Jilin University. The author has contributed to research in topics: Photothermal therapy & Chemistry. The author has an hindex of 30, co-authored 86 publications receiving 2688 citations.
Papers
More filters
Journal ArticleDOI
The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model
TL;DR: Results indicated that high-fat diet combined with multiple low doses of STZ (30 mg/kg at weekly intervals for 2 weeks) proved to be a better way for developing a stable animal model of type 2 diabetes, and this new model may be suitable for pharmaceutical screening.
Journal ArticleDOI
Controllable Synthesis of Stable Urchin-like Gold Nanoparticles Using Hydroquinone to Tune the Reactivity of Gold Chloride
TL;DR: In this article, the authors reported an aqueous synthesis of urchin-like gold nanoparticles (NPs) in the presence of hydroquinone through a seed-mediated growth approach.
Journal ArticleDOI
Carbon dots as a trackable drug delivery carrier for localized cancer therapy in vivo
Qinghui Zeng,Dan Shao,Xu He,Zhongyuan Ren,Wenyu Ji,Chongxin Shan,Songnan Qu,Jing Li,Li Chen,Qin Li +9 more
TL;DR: It is demonstrated that green-emitting CDs with a carboxyl-rich surface can be employed as a trackable drug delivery agent for localized cancer treatment in a mouse model and the stimuli-responsive non-covalent bonding between the nanodot carrier and the drug molecule is sufficiently stable in complex biological systems.
Journal ArticleDOI
Janus "nano-bullets" for magnetic targeting liver cancer chemotherapy.
TL;DR: This study demonstrates an intriguing targeting strategy for liver cancer treatment based on a novel Janus nano-bullet, aiming for utilization of nanotechnology to obtain safe andcient treatment of liver cancer.
Journal ArticleDOI
Janus Silver-Mesoporous Silica Nanocarriers for SERS Traceable and pH-Sensitive Drug Delivery in Cancer Therapy
TL;DR: A facile and cheap strategy was used to fabricate the novel Janus silver-mesoporous silica nanoparticles with excellent SPR and mesoporous properties for simultaneous SERS imaging and pH-responsive drug release, leading to the efficient cancer theranostic with less toxic effects.